pharmaphorum

AUGUST 25, 2022

The category is getting increasingly crowed, with Pfizer also anticipating approval of its BCMA-targeting bispecific elranatamab in the coming months, with several more multiple myeloma bispecifics coming through the pipeline from the likes of Regeneron, AbbVie, Amgen and Roche.

FDA 93

FDA Marketing Safety Patients 93

Pharmaceutical Technology

FEBRUARY 22, 2023

Developed by Sanofi and Regeneron, Praluent was approved by the FDA in July 2015. Both drugs come with a high price tag. Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US. Amgen’s Repatha was greenlit a month later. However, the case was brought back.

Pharma 104

Pharma Government FDA Sales 104

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

Rep-Lite

MARCH 21, 2024

Take for instance Libtayo which was the top-selling product for Regeneron Pharmaceuticals. There are rungs and each comes with both a price tag and an incentive. Product Type and Complexity The type of product being sold in medical sales can significantly impact the earnings potential for medical sales reps.

Medical sales 52

Medical sales Medical sales reps Medical Sales 52